Using mobile health tools to prevent heart disease after pregnancy complications
Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy
NA · Northwestern University · NCT06523569
This study tests if using a mobile health app and remote monitoring can help new parents who had high blood pressure during pregnancy improve their heart health compared to those who just get regular care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | Female |
| Sponsor | Northwestern University (other) |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT06523569 on ClinicalTrials.gov |
What this trial studies
This research aims to evaluate the effectiveness of two digital health interventions designed to improve cardiovascular health in individuals who experienced hypertensive disorders during pregnancy. Participants will be monitored through echocardiography and blood pressure assessments at 3 and 12 months postpartum. Those in the intervention group will use a mobile health application and a remote patient monitoring system alongside standard care, while the control group will receive usual care only. The study focuses on postpartum individuals to identify potential subclinical cardiac dysfunction and improve long-term health outcomes.
Who should consider this trial
Good fit: Ideal candidates are postpartum individuals who delivered at Northwestern Memorial Hospital and experienced new-onset hypertensive disorders of pregnancy.
Not a fit: Patients with chronic diseases prior to pregnancy or those who experienced severe complications like HELLP syndrome may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly reduce the risk of cardiovascular disease in women who have had hypertensive disorders during pregnancy.
How similar studies have performed: Other studies have shown promise with digital health interventions in managing cardiovascular risks, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Delivery at Northwestern Memorial Hospital (Prentice Women's Hospital) * Live birth at any gestational age * Pregnancy complicated by new-onset HDP (pre-eclampsia, eclampsia, or gestational hypertension) Exclusion Criteria: * HELLP syndrome * History of chronic diseases pre-pregnancy (hypertension, diabetes, cardiovascular disease, chronic renal disease) * Current Omron remote patient monitoring or Noom user * BMI\<18.5 kg/m2 at enrollment * Inadequate gestational weight gain or gestational weight loss
Where this trial is running
Chicago, Illinois
- Northwestern University, Dept. of Cardiology — Chicago, Illinois, United States (RECRUITING)
Study contacts
- Principal investigator: Priya M Freaney, MD — Northwestern University
- Study coordinator: Priya M Freaney, MD
- Email: priya.freaney@northwestern.edu
- Phone: (312) 664-3278
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hypertension in Pregnancy, Pre-Eclampsia, Eclampsia, Gestational Hypertension, digital health, echocardiogram, blood pressure